New Potential Biomarkers to Assess Efficacy of Protection Afforded by Vaccine Candidates Against Tuberculosis

Clinical Microbiology and Infection - United Kingdom
doi 10.1016/j.cmi.2019.02.010
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Vaccine Against Tuberculosis: What’s New?

BMC Infectious Diseases
Infectious Diseases
2014English

Potential Vaccine Candidates Against Nematodes of Veterinary Importance: An Overview

International Journal of Current Microbiology and Applied Sciences
2019English

High Antigen Dose Is Detrimental to Post-Exposure Vaccine Protection Against Tuberculosis

Frontiers in Immunology
AllergyImmunology
2018English

Protection Afforded by Cycle Helmets

BMJ
1994English

Potential of Recombinant Opa Proteins as Vaccine Candidates Against Hyperinvasive Meningococci

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2011English

Protection of Chickens Afforded by Commercial Lentogenic Vaccines Against Challenge Exposure to Velogenic Newcastle Disease Virus

Avian Diseases
Animal ScienceZoologyFood AnimalsImmunologyMicrobiology
1973English

Deletion ofnuoGfrom the Vaccine CandidateMycobacterium bovisBCG ΔureC::hlyImproves Protection Against Tuberculosis

mBio
VirologyMicrobiology
2016English

Protection Against Acute Hepatocellular Injury Afforded by Liver Fibrosis Is Independent of T Lymphocytes

PLoS ONE
Multidisciplinary
2016English

New Tuberculosis Vaccine to Support Tuberculosis Elimination

Universa Medicina
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy